Ani Pharmaceuticals (ANIP) Cash from Operations (2010 - 2026)
Ani Pharmaceuticals (ANIP) posted Cash from Operations of 58375000.0 for Q1 2026, up 92.23% sequentially from 30367000.0 in Q4 2025, and up 66.83% YoY from 34991000.0 in Q1 2025.
Ani Pharmaceuticals (ANIP) Cash from Operations (2010 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Cash from Operations for 17 years, with the latest figure at 58375000.0 in Q1 2026.
- Quarterly Cash from Operations rose 66.83% year-over-year to 58375000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 208609000.0 (up 158.37% YoY) and the FY2025 annual result came in at 185225000.0, up 189.34% from the prior year.
- Cash from Operations advanced to 58375000.0 in Q1 2026 per ANIP's latest filing, from 30367000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 75812000.0 in Q2 2025 and troughed at 18942000.0 in Q1 2022.
- A 5-year average of 23257235.29 and a median of 20626000.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2023: Cash from Operations plunged 4865.15% in 2022, then surged 1116.82% in 2023.
- Over 5 years, Cash from Operations stood at 4400000.0 in 2022, then soared by 1116.82% to 44740000.0 in 2023, then tumbled by 64.55% to 15860000.0 in 2024, then jumped by 91.47% to 30367000.0 in 2025, then jumped by 92.23% to 58375000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 58375000.0, 30367000.0, and 44055000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.58 Bn | 1.22 Bn | 165.89 Mn | 56.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.67 Mn |
| Jun 30, 2026 | 56.67 Mn |
| Mar 31, 2026 | 58.38 Mn |
| Mar 31, 2026 | 58.38 Mn |
| Dec 31, 2025 | 30.37 Mn |
| Dec 31, 2025 | 30.37 Mn |
| Sep 30, 2025 | 44.06 Mn |
| Sep 30, 2025 | 44.06 Mn |
| Jun 30, 2025 | 75.81 Mn |
| Jun 30, 2025 | 75.81 Mn |
| Mar 31, 2025 | 34.99 Mn |
| Mar 31, 2025 | 34.99 Mn |
| Dec 31, 2024 | 15.86 Mn |
| Dec 31, 2024 | 15.86 Mn |
| Sep 30, 2024 | 12.47 Mn |
| Sep 30, 2024 | 12.47 Mn |
| Jun 30, 2024 | 17.41 Mn |
| Jun 30, 2024 | 17.41 Mn |
| Mar 31, 2024 | 18.27 Mn |
| Mar 31, 2024 | 18.27 Mn |